Half-year report · HY
6951.TEDINET S100X4AK
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥82.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥196.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥87.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥11.9bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥15.8bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥12.9bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥34.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.1bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥13.9bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥14.1bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥9.8bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥18.7bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.9bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥9.8bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥10.9bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥226.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥222.5bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥229.7bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥82.7bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥85.8bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥143.8bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥136.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥131.6bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥36.0bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥36.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥34.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.6bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥37.7bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥9.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥17.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥855m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥5.9bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥17.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥192.55 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥365.55 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥213.6 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 63.5% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.3% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥3.2bn |
| Industrial Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥27.0bn |
| Industrial Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥27.0bn |
| Industrial Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥11.7bn |
| Medical Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥7.4bn |
| Medical Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥7.4bn |
| Medical Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥696m |
| Scientific And Measurement Instrumentsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥47.7bn |
| Scientific And Measurement Instrumentsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥47.7bn |
| Scientific And Measurement Instrumentsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.7bn |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥82.1bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥82.1bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥15.1bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥3.2bn |
| Industrial Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥28.7bn |
| Industrial Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥28.7bn |
| Industrial Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.6bn |
| Medical Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥6.4bn |
| Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥6.4bn |
| Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥394m |
| Scientific And Measurement Instrumentsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥52.2bn |
| Scientific And Measurement Instrumentsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥52.2bn |
| Scientific And Measurement Instrumentsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥4.0bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥87.2bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥87.2bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥19.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 533
| Item | Context | Value | Unit |
|---|---|---|---|
| Subsidy income ope cf | Prior1InterimDuration | -20000000 | JPY |
| Subsidy income ope cf | InterimDuration | -20000000 | JPY |
| Interest and dividends income ope cf | Prior1InterimDuration | -209000000 | JPY |
| Interest and dividends income ope cf | InterimDuration | -226000000 | JPY |
| Interest expenses ope cf | Prior1InterimDuration | 58000000 | JPY |
| Interest expenses ope cf | InterimDuration | 44000000 | JPY |
| Loss on sales of notes and accounts receivable trade ope cf | Prior1InterimDuration | 1000000 | JPY |
| Loss on sales of notes and accounts receivable trade ope cf | InterimDuration | 1000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1InterimDuration | 11944000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | InterimDuration | 10917000000 | JPY |
| Decrease increase in inventories ope cf | Prior1InterimDuration | -6220000000 | JPY |
| Decrease increase in inventories ope cf | InterimDuration | -2323000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1InterimDuration | -2329000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | InterimDuration | -3394000000 | JPY |
| Increase decrease in contract liabilities ope cf | Prior1InterimDuration | 1877000000 | JPY |
| Increase decrease in contract liabilities ope cf | InterimDuration | -4258000000 | JPY |
| Other net ope cf | Prior1InterimDuration | -458000000 | JPY |
| Other net ope cf | InterimDuration | -1987000000 | JPY |
| Subtotal ope cf | Prior1InterimDuration | 21411000000 | JPY |
| Subtotal ope cf | InterimDuration | 14311000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1InterimDuration | 203000000 | JPY |
| Interest and dividends income received ope cf inv cf | InterimDuration | 223000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1InterimDuration | -74000000 | JPY |
| Interest expenses paid ope cf fin cf | InterimDuration | -44000000 | JPY |
| Sales of trade receivables paid | Prior1InterimDuration | -1000000 | JPY |
| Sales of trade receivables paid | InterimDuration | -1000000 | JPY |
| Income taxes paid refund ope cf | Prior1InterimDuration | -5604000000 | JPY |
| Income taxes paid refund ope cf | InterimDuration | -5470000000 | JPY |
| Proceeds from subsidy ope cf | Prior1InterimDuration | 1312000000 | JPY |
| Proceeds from subsidy ope cf | InterimDuration | 20000000 | JPY |
| Net cash provided by used in operating activities | Prior1InterimDuration | 17246000000 | JPY |
| Net cash provided by used in operating activities | InterimDuration | 9038000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1InterimDuration | － | JPY |
| Proceeds from sales of investment securities inv cf | InterimDuration | 1052000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1InterimDuration | -1324000000 | JPY |
| Purchase of property plant and equipment inv cf | InterimDuration | -4821000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1InterimDuration | 40000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | InterimDuration | 39000000 | JPY |
| Purchase of intangible assets inv cf | Prior1InterimDuration | -289000000 | JPY |
| Purchase of intangible assets inv cf | InterimDuration | -330000000 | JPY |
| Proceeds from sales of intangible assets inv cf | Prior1InterimDuration | － | JPY |
| Proceeds from sales of intangible assets inv cf | InterimDuration | 4000000 | JPY |
| Payments for transfer of business2 inv cf | Prior1InterimDuration | -150000000 | JPY |
| Payments for transfer of business2 inv cf | InterimDuration | － | JPY |
| Other net inv cf | Prior1InterimDuration | 160000000 | JPY |
| Other net inv cf | InterimDuration | -24000000 | JPY |
| Net cash provided by used in investment activities | Prior1InterimDuration | -1562000000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -4079000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -3738000000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -2481000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |